FATE
Fate Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.65 / 10
Netural
The firm exhibits weak fundamental strength scoring 3.6/10. Supportive aspects: Interest coverage ratio (EBIT / Interest expense) (%) and Profit-MV, whereas limitations surface in Total operating revenue (YoY growth rate %) and Operating revenue (YoY growth rate %). Investment verdict: challenging.
Analysis Checks(5/10)
Revenue-MV
Value-2.74
Score1/3
Weight10.33%
1M Return4.24%
Value-2.74
Score1/3
Weight10.33%
1M Return4.24%
Days sales outstanding
Value107.98
Score0/3
Weight-9.10%
1M Return-5.18%
Value107.98
Score0/3
Weight-9.10%
1M Return-5.18%
Net income-Revenue
Value-0.17
Score2/3
Weight20.55%
1M Return8.45%
Value-0.17
Score2/3
Weight20.55%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.05%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.05%
1M Return-1.11%
Asset-MV
Value-0.50
Score0/3
Weight14.66%
1M Return5.75%
Value-0.50
Score0/3
Weight14.66%
1M Return5.75%
Total operating revenue (YoY growth rate %)
Value-55.17
Score1/3
Weight-1.50%
1M Return-0.79%
Value-55.17
Score1/3
Weight-1.50%
1M Return-0.79%
Profit-MV
Value0.46
Score2/3
Weight20.53%
1M Return8.45%
Value0.46
Score2/3
Weight20.53%
1M Return8.45%
PB-ROE
Value-0.63
Score3/3
Weight27.84%
1M Return12.83%
Value-0.63
Score3/3
Weight27.84%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value-55.17
Score1/3
Weight-1.45%
1M Return-0.76%
Value-55.17
Score1/3
Weight-1.45%
1M Return-0.76%
Cash-MV
Value-0.07
Score2/3
Weight20.18%
1M Return8.41%
Value-0.07
Score2/3
Weight20.18%
1M Return8.41%
Revenue-MV
Value-2.74
Score1/3
Weight10.33%
1M Return4.24%
Value-2.74
Score1/3
Weight10.33%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value-55.17
Score1/3
Weight-1.50%
1M Return-0.79%
Value-55.17
Score1/3
Weight-1.50%
1M Return-0.79%
Days sales outstanding
Value107.98
Score0/3
Weight-9.10%
1M Return-5.18%
Value107.98
Score0/3
Weight-9.10%
1M Return-5.18%
Profit-MV
Value0.46
Score2/3
Weight20.53%
1M Return8.45%
Value0.46
Score2/3
Weight20.53%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight20.55%
1M Return8.45%
Value-0.17
Score2/3
Weight20.55%
1M Return8.45%
PB-ROE
Value-0.63
Score3/3
Weight27.84%
1M Return12.83%
Value-0.63
Score3/3
Weight27.84%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.05%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.05%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-55.17
Score1/3
Weight-1.45%
1M Return-0.76%
Value-55.17
Score1/3
Weight-1.45%
1M Return-0.76%
Asset-MV
Value-0.50
Score0/3
Weight14.66%
1M Return5.75%
Value-0.50
Score0/3
Weight14.66%
1M Return5.75%
Cash-MV
Value-0.07
Score2/3
Weight20.18%
1M Return8.41%
Value-0.07
Score2/3
Weight20.18%
1M Return8.41%
Is FATE undervalued or overvalued?
- FATE scores 3.65/10 on fundamentals and holds a Fair valuation at present. Backed by its -37.61% ROE, -2187.11% net margin, -0.77 P/E ratio, 0.56 P/B ratio, and 18.90% earnings growth, these metrics solidify its Netural investment rating.
